Inquiry Basket
| IUPAC Name: | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-triethylsilyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-triethylsilyloxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
| Description: | 2',7-Bis(triethylsilyl)paclitaxel is a Paclitaxel (P132500) related compound which is an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. 2',7-Bis(triethylsilyl)paclitaxel is used in the preparation of paclitaxel from 10-deacetylpaclitaxel via regioselective silylation, acetylation and desilylation. |
| Molecular Weight: | 1082.43 |
| Molecular Formula: | C59H79NO14Si2 |
| Canonical SMILES: | CC[Si](CC)(CC)OC1CC2C(CO2)(C3C1(C(=O)C(C4=C(C(CC(C3OC(=O)C5=CC=CC=C5)(C4(C)C)O)OC(=O)C(C(C6=CC=CC=C6)NC(=O)C7=CC=CC=C7)O[Si](CC)(CC)CC)C)OC(=O)C)C)OC(=O)C |
| InChI: | InChI=1S/C59H79NO14Si2/c1-13-75(14-2,15-3)73-44-34-45-58(36-68-45,72-39(9)62)50-52(71-54(65)42-32-26-21-27-33-42)59(67)35-43(37(7)46(56(59,10)11)48(69-38(8)61)51(63)57(44,50)12)70-55(66)49(74-76(16-4,17-5)18-6)47(40-28-22-19-23-29-40)60-53(64)41-30-24-20-25-31-41/h19-33,43-45,47-50,52,67H,13-18,34-36H2,1-12H3,(H,60,64)/t43-,44-,45+,47-,48+,49+,50-,52-,57+,58-,59+/m0/s1 |
| InChI Key: | WPGSFSCXNLAODB-SDXTULIHSA-N |
| Melting Point: | 138-140°C |
| Solubility: | Chloroform (Slightly), Ethanol (Slightly) |
| Appearance: | White to Off-White Solid |
| Storage: | -20°C, Inert atmosphere |
| References: | Letourneau, P.C., et al. J. Cell Biol., 98, 1355 (1984); Manfredi, J.J., et al. Pharmacol. Ther., 25, 83 (1984); Danesi, R., et al. Mol. Pharmacol., 47, 1106 (1995); Markman, M., et al. Expert. Opin. Pharmacother., 3, 755 (2002); Stone, G.W., et al. N. Engl. J. Med., 350, 221 (2004); Lee, N. Y., Cho. J. S., Repub. Korean Kongkae Taeho Kongbo (2013), KR 2013035731 A 20130409. |
![((2R,5S,10aS,10bS)-5-Benzyl-8,10b-bis(benzyloxy)-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester](/buildingblock.v1/images/structure-default.jpg)
Catalog: BB055105
((2R,5S,10aS,10bS)-5-Benzyl-8,10b-bis(benzyloxy)-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
Catalog: BB074488
((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester
Detail
Catalog: BB069926
((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
Catalog: BB069173
((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane
Detail
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Global Delivery
Warehouses in multiple cities to ensure fast delivery
Quality Assurance
Strict process parameter control to ensure product quality
Large Stock
> 20,000 building blocks and intermediates from stock
Process Scale-up
Process scale-up from lab to industrial scale
Flexible Batch Size
Flexible batch size for diverse industrial demandsRelated Functional Groups
Other Building Blocks
Customers Also Viewed
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products
